Context-dependent translation inhibition as a cancer therapeutic modality.
Saved in:
| Title: | Context-dependent translation inhibition as a cancer therapeutic modality. |
|---|---|
| Authors: | Diamond PD; Interdict Bio Inc., South San Francisco, CA, USA., Sauer PV; Interdict Bio Inc., South San Francisco, CA, USA., Holm M; Interdict Bio Inc., South San Francisco, CA, USA., Swanson-Swett CJ; Interdict Bio Inc., South San Francisco, CA, USA., Ferguson L; Interdict Bio Inc., South San Francisco, CA, USA., Bratset NM; Interdict Bio Inc., South San Francisco, CA, USA., Wienker GW; Interdict Bio Inc., South San Francisco, CA, USA., Sim JS; Interdict Bio Inc., South San Francisco, CA, USA., Adams HK; Interdict Bio Inc., South San Francisco, CA, USA., Kenner L; Interdict Bio Inc., South San Francisco, CA, USA., Meyers M; Interdict Bio Inc., South San Francisco, CA, USA., Gygi D; Interdict Bio Inc., South San Francisco, CA, USA., Könst ZA; Interdict Bio Inc., South San Francisco, CA, USA., Bahmanyar SS; Interdict Bio Inc., South San Francisco, CA, USA., Hamann LG; Interdict Bio Inc., South San Francisco, CA, USA., Schuller AP; Interdict Bio Inc., South San Francisco, CA, USA. aschuller@interdictbio.com. |
| Source: | Nature communications [Nat Commun] 2026 Feb 24; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-026-69891-2 |
